comparemela.com
Home
Live Updates
Arcturus Therapeutics : Submitted New Drug Application to Manufacture and Market ARCT-154, Next Generation mRNA Vaccine against COVID-19, in Japan - Form 8-K : comparemela.com
Arcturus Therapeutics : Submitted New Drug Application to Manufacture and Market ARCT-154, Next Generation mRNA Vaccine against COVID-19, in Japan - Form 8-K
Submitted New Drug Application to Manufacture and Market ARCT-154,
Next Generation mRNA Vaccine against COVID-19, in Japan
Meiji Holdings Co., Ltd. announces... | April 28, 2023
Related Keywords
Japan ,
Australia ,
Vietnam ,
Republic Of ,
Meiji ,
Hokkaido ,
Japanese ,
Seika Pharma ,
Arcalis Inc ,
Arcturus Therapeutics Holdings Inc ,
Arcturus Therapeutics Inc ,
Meiji Seika Pharma Co Ltd ,
Meiji Holdings Co Ltd ,
Axcelead Inc ,
Submitted New Drug Application ,
New Drug Application ,
Arcturus Therapeutics ,
Meiji Seika Pharma ,
Minami Soma City ,
Therapeutics Holdings ,
Arcturus Therapeutics Holdings Inc Stock Exchange ,
News ,
Information ,
Press Release ,
Ubmitted ,
Few ,
Drug ,
Application ,
O ,
Manufacture ,
End ,
Market ,
Text ,
Generation ,
Rna ,
Vaccine ,
Against ,
N ,
Oldings Arct Us03969t1097 ,
comparemela.com © 2020. All Rights Reserved.